about
Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model.Difference in agr dysfunction and reduced vancomycin susceptibility between MRSA bacteremia involving SCCmec types IV/IVa and I-III.A case of pseudomembranous colitis after voriconazole therapy.Teicoplanin dosing strategy for treatment of Staphylococcus aureus in Korean patients with neutropenic feverThe demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general populationInappropriateness of quinolone in scrub typhus treatment due to gyrA mutation in Orientia tsutsugamushi Boryong strainClinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies.Cytomegalovirus ventriculoencephalitis after unrelated double cord blood stem cell transplantation with an alemtuzumab-containing preparative regimen for Philadelphia-positive acute lymphoblastic leukemia.Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea.A Case of Spontaneous Bacterial Peritonitis with Bacteremia Caused by Shewanella algae.Immunity and the burden of herpes zoster.Primary Sternal Osteomyelitis caused by Staphylococcus aureus in an Immunocompetent Adult.Postoperative Trichosporon asahii spondylodiscitis after open lumbar discectomy: a case report.Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or older.Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy.Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia.Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.Implementation of Hospital Policy for Healthcare Workers and Patients Exposed to Varicella-Zoster VirusT-cell lymphoproliferative disorder following a full haplotype-mismatched haematopoietic stem cell transplant in a patient with acute myeloid leukaemiaA Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy AdultsTriparesis caused by gas-containing extensive epidural abscess secondary to Aeromonas hydrophila infection of a thoracic vertebroplasty: a case reportFLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemiaAllogeneic Stem Cell Transplantation in First Complete Remission Enhances Graft-versus-Leukemia Effect in Adults with Acute Lymphoblastic Leukemia: Antileukemic Activity of Chronic Graft-versus-Host DiseaseClinical Characteristics and Antimicrobial Susceptibility Trends in Bacteremia: An 11-Year Single-Center ExperienceTrends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015Reply letter: trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015Erratum: Carbapenem-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea
P50
Q33724436-88FA0EE1-31F3-4012-AFC7-BCD471B2279DQ34477769-06128D84-27B1-4296-8DBA-709DC03C58B2Q34631174-A3A6AF1D-A965-47C0-9D42-AE07E8001072Q35014842-C72B4857-12DA-4580-A506-6578E8CE7FFCQ36302252-1E496FCB-96D7-4903-9E66-264FFD8EF040Q36841060-9AB8829C-2B6D-41BA-9365-3B33AF605C3DQ39193577-90C00D86-C242-48F0-B69E-F983C2ADFA48Q39773124-2AD6B5E0-299D-4F85-84EA-9CDD2C9F9721Q40530202-E62D4CF3-768F-411B-B514-69FAB54B19E9Q41558612-7BA19262-598C-4151-B9F1-A4952CC95C2AQ42242684-9FFA6904-72D6-4913-B569-986CC56D25ECQ42366698-E1AA5E84-FEFC-40FF-A8F9-B17CCE9AEF17Q42645467-CB165270-4E01-48AB-AADB-489390C73E9BQ45271053-4A41EEA8-E28B-4099-A4FB-30F32A0BE043Q46240270-1019C23A-C52E-4E76-8071-7E3D2D68026CQ46966671-9B4645B2-8671-4A82-9160-CF51C7AB66D5Q51174417-B20D1345-A17B-4C00-B56A-C22B4F5F164FQ53132522-7D2566CA-2D56-4CB3-9A38-9AC52F172302Q53210874-44EE946F-9423-42E4-A45A-C688BD1714FAQ54354143-91806A55-1A65-4492-A14E-0CFF81D5F302Q58700966-08662E30-3E02-410C-A8B4-5A4D6D3A60F3Q60627326-83A92C88-4727-4B30-BA79-AA73391C6954Q61447769-F3C58804-7EDA-4BF9-8131-106F99A0219AQ62022691-670A5AED-489B-4E7F-BAC2-1D2438D0BC57Q62022698-0B0E6A36-80A0-4350-AD68-E0D882B935EFQ62022718-74AE1DE1-8EAA-472E-B0CA-57CB2339C4DAQ64103135-46E10B8F-4101-47D9-8AB9-28A9092E4BAAQ90126832-62D2F378-79F6-4C93-9E32-1B4FE4FB522EQ91931159-4F6A401D-5521-434D-B71E-9C54A7BD41C3Q92391869-840B9834-E989-447D-A4AC-754552A08DC0
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Su-Mi Choi
@ast
Su-Mi Choi
@en
Su-Mi Choi
@es
Su-Mi Choi
@nl
Su-Mi Choi
@sl
type
label
Su-Mi Choi
@ast
Su-Mi Choi
@en
Su-Mi Choi
@es
Su-Mi Choi
@nl
Su-Mi Choi
@sl
prefLabel
Su-Mi Choi
@ast
Su-Mi Choi
@en
Su-Mi Choi
@es
Su-Mi Choi
@nl
Su-Mi Choi
@sl
P106
P1153
7408120168
P21
P31
P496
0000-0002-8187-5110
P569
2000-01-01T00:00:00Z